antibody drug conjugates - Globe Thesis

Keyword [antibody drug conjugates] Result: 1 - 19 \| Page: 1 of 1
1.	Anti-Her2 Antibody Stability Modification And Function Optimization
2.	Preparation And Biological Activity Study Of Targeted Delivery For Platinum Drugs
3.	Preparation Of Anti-ansamitocin Monoclonal Antibodies And Development Of ELISA Method
4.	Solid-state Fermentation Of Ansamitocins And Preparation Of Ansamitocin P-0
5.	The Research Of A New Cancer Targeted Drug Conjugate Of Bufalin Derivative And The Anti-tumor Effect Research Of Compounds Acting On Mitochondria
6.	Endocytic Mechanisms Of The Antibody-Drug Conjugates Targeting HER2-Positive Breast Cancer Cell
7.	Stiudies On The Design Of Novel-carrier And Novel-target Based Antibody-drug Conjugates
8.	Exploration Of The Feasibility Of Peptide/Major Histocompatibility Complex (pMHC) As Antibody-drug Conjugates (ADCs) Target
9.	Study Of Human Anti-Prostate Specific Membrane Antigen (PSMA) Antibody-Drug Conjugates
10.	The Pharmacodynamics And Pharmacokinetics Study Of Humanized 5A12 Antibody-Drug Conjugates Targeting HAb18G/CD147-Positive Colorectal Carcinoma
11.	The Design Of Antibody-drug Conjugates And Studies On Their Specific Antitumor Activities
12.	Study On The Factors Of Safety And Efficacy Of Novel Antibody-drug Conjugates
13.	Technology-Mediated Functionalization of Proteins and Antibodies Using a Continuous Flow Microreactor
14.	Construction Of A Pan-Solid Tumor-Associated Antigen Atlas And Its Application To Antibody-Drug Conjugates And Chimeric Antigen Receptor T Cells
15.	Engases-Catalyzed Glycoengineering Of Glycoproteins And Novel Antibody Drug Discovery
16.	Design,Synthesis And Biological Evaluation Of Novel Antibody-Drug Conjugates With Anti-Tumor Effects
17.	The Design Of Novel Anti-EGFR Antibody-drug Conjugates And Studies On Their Antitumor Effect
18.	Antitumor Activity And Mechanism Of Antibody-drug Conjugates Targeting Cell Adhesion Molecules
19.	The Mechanisms Underlying The Synergistic Antitumor Activity Of Multi-targeted Tyrosine Kinase Inhibitor Famitinib And The Third-generation EGFR Inhibitor HS-10296 As Well As The Antitumor Activity Of The Novel Antibody-drug Conjugates Targeting CD79b
<<First <Prev Next> Last>> Jump to